Comment from Daiichi Sankyo, Inc.

Summary: Daiichi Sankyo, Inc. supports the proposed pilot program, emphasizing its potential to improve trial efficiency and safety monitoring while maintaining human oversight. They provide specific recommendations on trial types, participant selection, collaboration models, and evaluation metrics to ensure a scientifically rigorous and operationally feasible implementation.